Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-25-005173
Filing Date
2025-02-26
Accepted
2025-02-26 10:09:14
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 mbrx20250226_424b5.htm 424B5 360438
2 moleculinnewlogoresized.jpg GRAPHIC 7783
  Complete submission text file 0001437749-25-005173.txt   372305
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671997 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-280064 | Film No.: 25666767
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)